An incorrect conclusion would be that “increased s-IL6R reduces the risk of developing IBD”; s-IL6R was used as an indirect marker for reduced membrane-bound IL6R and subsequent classic signaling. This evidence concerns the gene IL6R and inflammatory bowel disease.